Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
- 28 November 2007
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 8 (3) , 167-178
- https://doi.org/10.1016/s1473-3099(07)70264-5
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Antiviral Drug Resistance: Clinical Consequences and Molecular AspectsSeminars in Liver Disease, 2006
- HBV drug resistance: Mechanisms, detection and interpretationJournal of Hepatology, 2006
- A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis BGastroenterology, 2005
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B (e-CHB) patients completely responders during 5 years of therapyJournal of Hepatology, 2004
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆Gastroenterology, 2004
- Natural History and Prognosis of Hepatitis BSeminars in Liver Disease, 2003
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal studyJournal of Hepatology, 1994